Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Dec;15(12):646-654.

The Spectrum of Reflux Phenotypes

Affiliations

The Spectrum of Reflux Phenotypes

Lisa B Mahoney et al. Gastroenterol Hepatol (N Y). 2019 Dec.

Abstract

The focus on a symptom-based definition for gastroesophageal reflux disease (GERD) in adults and children has contributed to widespread use of acid suppression medications in patients with so-called typical reflux symptoms to treat the possibility of acid-mediated disease. Diagnostic testing with upper endoscopy, esophageal biopsies, ambulatory reflux monitoring, and/or esophageal manometry is often pursued when patients do not respond optimally to these medications. By using information from this diagnostic testing, GERD has shifted from a single diagnosis to a phenotypic spectrum, and each phenotype has unique pathophysiologic mechanisms driving symptom perception. Understanding these mechanisms is important to tailor individualized treatment plans and guide therapeutic interventions. The aim of this article is to discuss the different reflux phenotypes, the utility of esophageal reflux testing, the mechanisms underlying symptoms, and the management strategies for each phenotype.

Keywords: Multichannel intraluminal impedance; functional heartburn; nonerosive reflux disease; proton pump inhibitor; reflux hypersensitivity.

PubMed Disclaimer

Conflict of interest statement

This work was supported by the NIH NIDDK R01 DK097112 (RR), the Thrasher Research Fund (LM), and the Boston Children’s Hospital Translational Research Program Senior Investigator Award (RR). The authors have no relevant conflicts of interest to disclose.

Figures

Figure.
Figure.
Proposed algorithm for the approach to bothersome symptoms in older children. EGD, esophagogastroduodenoscopy; EoE, eosinophilic esophagitis; GERD, gastroesophageal reflux disease; H2RA, histamine 2 receptor antagonist; NERD, nonerosive reflux disease; pH-MII, multichannel intraluminal impedance with pH; PPI, proton pump inhibitor.

Similar articles

Cited by

References

    1. Eusebi LH, Ratnakumaran R, Yuan Y, Solaymani-Dodaran M, Bazzoli F, Ford AC. Global prevalence of, and risk factors for, gastro-oesophageal reflux symptoms: a meta-analysis. Gut. 2018;67(3):430–440. - PubMed
    1. Singendonk M, Goudswaard E, Langendam M et al. Prevalence of gastroesophageal reflux disease symptoms in infants and children: a systematic review. J Pediatr Gastroenterol Nutr. 2019;68(6):811–817. - PubMed
    1. Peery AF, Crockett SD, Murphy CC et al. Burden and cost of gastrointestinal, liver, and pancreatic diseases in the United States: update 2018. Gastroenterology. 2019;156(1):254–272.e11. - PMC - PubMed
    1. Vakil N, van Zanten SV, Kahrilas P, Dent J, Jones R. Global Consensus Group. The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus. Am J Gastroenterol. 2006;101(8):1900–1920. quiz 1943. - PubMed
    1. Vandenplas Y, Rudolph CD, Di Lorenzo C et al. North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition; European Society for Pediatric Gastroenterology, Hepatology, and Nutrition. Pediatric gastroesophageal reflux clinical practice guidelines: joint recommendations of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition (NASPGHAN) and the European Society for Pediatric Gastroenterology, Hepatology, and Nutrition (ESPGHAN) J Pediatr Gastroenterol Nutr. 2009;49(4):498–547. - PubMed

LinkOut - more resources